哌甲酯-话题@MedSci - 梅斯（MedSci）

#哌甲酯#

8篇内容 | 1457人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2173655, encodeId=80c821e36550c, content=<a href='/topic/show?id=3cbe9e7892e' target=_blank style='color:#2F92EE;'>#阿尔茨海默病#</a> <a href='/topic/show?id=8d9939905da' target=_blank style='color:#2F92EE;'>#哌甲酯#</a>, objectTitle=Alzheimer&Dementia：哌甲酯对阿尔茨海默病神经精神症状的影响：来自 ADMET 2 研究的证据, objectType=article, longId=804107, objectId=ad2a80410e4a, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/142214-forgetting.jpg, objectUrl=/article/show_article.do?id=ad2a80410e4a, replyNumber=0, likeNumber=104, createdTime=2023-12-08, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=ad2a80410e4a, moduleTitle=Alzheimer&Dementia：哌甲酯对阿尔茨海默病神经精神症状的影响：来自 ADMET 2 研究的证据, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ad2a80410e4a)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2118841, encodeId=e24721188418f, content=<a href='/topic/show?id=6fdf650130a' target=_blank style='color:#2F92EE;'>#注意力缺陷多动障碍#</a>（ADHD）药物在<a href='/topic/show?id=f8b15210674' target=_blank style='color:#2F92EE;'>#怀孕#</a>期间被越来越多地使用，包括<a href='/topic/show?id=8d9939905da' target=_blank style='color:#2F92EE;'>#哌甲酯#</a>等。, objectTitle=MP：母体孕期暴露于ADHD药物其子代的长期结局, objectType=article, longId=761798, objectId=0ffce6179857, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668019552973_4754896.png, objectUrl=/article/show_article.do?id=0ffce6179857, replyNumber=0, likeNumber=128, createdTime=2023-03-11, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=0ffce6179857, moduleTitle=MP：母体孕期暴露于ADHD药物其子代的长期结局, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0ffce6179857)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1954454, encodeId=0dbc19544548a, content=<a href='/topic/show?id=8d9939905da' target=_blank style='color:#2F92EE;'>#哌甲酯#</a>, objectTitle=Lancet Neurology: 金刚烷胺、莫达非尼和哌甲酯治疗多发性硬化症疲劳的安全性和有效性：一项随机、交叉、双盲试验, objectType=article, longId=206554, objectId=f37e2065542a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f37e2065542a, replyNumber=0, likeNumber=116, createdTime=2022-01-09, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f37e2065542a, moduleTitle=Lancet Neurology: 金刚烷胺、莫达非尼和哌甲酯治疗多发性硬化症疲劳的安全性和有效性：一项随机、交叉、双盲试验, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f37e2065542a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1954453, encodeId=4708195445337, content=<a href='/topic/show?id=8d9939905da' target=_blank style='color:#2F92EE;'>#哌甲酯#</a>, objectTitle=FDA批准用于治疗ADHD的Adhansia XR（盐酸哌甲酯）缓释胶囊CII, objectType=article, longId=161550, objectId=2e87161550a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e87161550a1, replyNumber=0, likeNumber=0, createdTime=2019-10-25, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e87161550a1, moduleTitle=FDA批准用于治疗ADHD的Adhansia XR（盐酸哌甲酯）缓释胶囊CII, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2e87161550a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1954452, encodeId=bd7a1954452b1, content=<a href='/topic/show?id=8d9939905da' target=_blank style='color:#2F92EE;'>#哌甲酯#</a>, objectTitle=Lannett公司获得盐酸哌甲酯ER片剂的许可, objectType=article, longId=145960, objectId=caef14596041, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=caef14596041, replyNumber=0, likeNumber=82, createdTime=2019-07-16, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=caef14596041, moduleTitle=Lannett公司获得盐酸哌甲酯ER片剂的许可, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=caef14596041)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1954451, encodeId=098a195445179, content=<a href='/topic/show?id=8d9939905da' target=_blank style='color:#2F92EE;'>#哌甲酯#</a>, objectTitle=BMJ：哌甲酯治疗儿童及青少年注意缺陷多动障碍（ADHD）是否增加心血管风险？, objectType=article, longId=69661, objectId=8841696614e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8841696614e, replyNumber=0, likeNumber=89, createdTime=2016-12-13, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8841696614e, moduleTitle=BMJ：哌甲酯治疗儿童及青少年注意缺陷多动障碍（ADHD）是否增加心血管风险？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=8841696614e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1954450, encodeId=fb2e1954450b5, content=<a href='/topic/show?id=8d9939905da' target=_blank style='color:#2F92EE;'>#哌甲酯#</a>, objectTitle=Cochrane Review：哌甲酯药物治疗小儿多动症，有利亦有弊, objectType=article, longId=59521, objectId=b2a459521c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2a459521c0, replyNumber=0, likeNumber=97, createdTime=2016-01-26, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2a459521c0, moduleTitle=Cochrane Review：哌甲酯药物治疗小儿多动症，有利亦有弊, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b2a459521c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1954449, encodeId=3be7195444926, content=<a href='/topic/show?id=8d9939905da' target=_blank style='color:#2F92EE;'>#哌甲酯#</a>, objectTitle=AJP：西酞普兰+哌甲酯治疗老年抑郁症, objectType=article, longId=49104, objectId=cba649104ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cba649104ea, replyNumber=0, likeNumber=91, createdTime=2015-10-12, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cba649104ea, moduleTitle=AJP：西酞普兰+哌甲酯治疗老年抑郁症, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=cba649104ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1954448, encodeId=a0bc19544483b, content=<a href='/topic/show?id=8d9939905da' target=_blank style='color:#2F92EE;'>#哌甲酯#</a>, objectTitle=托莫西汀与哌甲酯抗ADHD等效, objectType=article, longId=3818, objectId=9f61381845, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f61381845, replyNumber=0, likeNumber=88, createdTime=2012-10-31, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f61381845, moduleTitle=托莫西汀与哌甲酯抗ADHD等效, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9f61381845)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

哌甲酯

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#阿尔茨海默病# #哌甲酯#

Alzheimer&Dementia：哌甲酯对阿尔茨海默病神经精神症状的影响：来自 ADMET 2 研究的证据

2023-12-08发表于上海

侠胆医心 (审核中...)

前往app查看评论内容

#注意力缺陷多动障碍#（ADHD）药物在#怀孕#期间被越来越多地使用，包括#哌甲酯#等。

MP：母体孕期暴露于ADHD药物其子代的长期结局

2023-03-11发表于上海

仁医06 (审核中...)

前往app查看评论内容

#哌甲酯#

Lancet Neurology: 金刚烷胺、莫达非尼和哌甲酯治疗多发性硬化症疲劳的安全性和有效性：一项随机、交叉、双盲试验

2022-01-09

仁医06 (审核中...)

前往app查看评论内容

#哌甲酯#

FDA批准用于治疗ADHD的Adhansia XR（盐酸哌甲酯）缓释胶囊CII

2019-10-25

仁医06 (审核中...)

前往app查看评论内容

#哌甲酯#

Lannett公司获得盐酸哌甲酯ER片剂的许可

2019-07-16

仁医06 (审核中...)

前往app查看评论内容

#哌甲酯#

BMJ：哌甲酯治疗儿童及青少年注意缺陷多动障碍（ADHD）是否增加心血管风险？

2016-12-13

仁医06 (审核中...)

前往app查看评论内容

#哌甲酯#

Cochrane Review：哌甲酯药物治疗小儿多动症，有利亦有弊

2016-01-26

仁医06 (审核中...)

前往app查看评论内容

#哌甲酯#

AJP：西酞普兰+哌甲酯治疗老年抑郁症

2015-10-12

仁医06 (审核中...)

前往app查看评论内容

#哌甲酯#

托莫西汀与哌甲酯抗ADHD等效

2012-10-31

科室
- - 订阅+
  - 更多科室
工具
服务